Related Experiment Video
Updated: May 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association Between Systemic Inflammation Response Index, Worsening of Left Ventricular Systolic Function and
Huangtao Ruan1,2, Xiaozhao Lu2,3, Huan Lu2,3,4
1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Insights
High systemic inflammation response index (SIRI) is linked to worsening left ventricular systolic function in coronary artery disease (CAD) patients. This worsening also contributes to cardiovascular and all-cause mortality in CAD.
Area of Science:
- Cardiology
- Inflammation Research
- Echocardiography
Background:
- Inflammation is a key factor in coronary artery disease (CAD) progression and poor prognosis.
- Worsening left ventricular (LV) systolic function significantly impacts CAD patient outcomes.
- The direct link between inflammation and the decline of LV systolic function in CAD remains unclear.
Purpose of the Study:
- To investigate the association between the systemic inflammation response index (SIRI) and the worsening of LV systolic function in patients with CAD.
- To determine if worsening LV systolic function mediates the relationship between SIRI and mortality in CAD patients.
Main Methods:
- Retrospective analysis of patients from the Cardiorenal Improvement-II study (2007-2020) with baseline and follow-up echocardiograms.
- Stratification of patients into four groups based on SIRI quartiles.
- Primary endpoint: a ≥10% decrease in LV ejection fraction within 12 months post-discharge.
- Secondary endpoints: cardiovascular and all-cause mortality, analyzed using logistic regression and mediation analysis.
Main Results:
- Out of 6307 CAD patients, 8.3% experienced worsening LV systolic function within a year.
- Patients in the highest SIRI quartile (Q4, ≥2.61) showed a significantly higher risk of worsening LV systolic function (aOR: 1.52, P=0.003).
- Worsening LV systolic function mediated 4.0% of the association between SIRI and cardiovascular mortality, and 2.0% with all-cause mortality.
Conclusions:
- Elevated SIRI is a significant risk factor for the deterioration of LV systolic function in CAD patients.
- The decline in LV systolic function associated with high SIRI contributes to increased mortality.
- Targeting inflammation through anti-inflammatory treatments may offer a therapeutic strategy to improve outcomes for CAD patients.
Background:
Inflammation contributes substantially to the progression and adverse prognosis of coronary artery disease (CAD). Worsening of left ventricular (LV) systolic function is a key contributor to poor prognosis in CAD patients. However, whether inflammation influences prognosis through worsening of left ventricular systolic function remains uncertain.
Methods:
This retrospective study enrolled patients from Cardiorenal Improvement-II who were initially hospitalised between 2007 and 2020 and had both baseline and follow-up echocardiographic information. Participants were stratified by systemic inflammation response index (SIRI) into 4 quartiles (Q1-Q4) for comparison. Worsening of LV systolic function served as the primary endpoint and was identified by an absolute decrease of 10% or more in LV ejection fraction from baseline to 12 months following hospital discharge. Secondary outcomes included cardiovascular and all-cause mortality. Logistic regression models were utilized to evaluate the association of SIRI with worsening of left ventricular systolic function. Mediation analysis was used to investigate the proportion of fatalities mediated by worsening of left ventricular systolic function.
Results:
Among the 6307 enrolled participants with CAD (62.0 ±10.7 years, 20.6% female), a total of 521 (8.3%) worsening of left ventricular systolic function occurred in 1 year, and 523 (8.3%) cardiovascular deaths and 1022 (16.2%) all-cause deaths were recorded with a median observation period of 4.2 years. After fully adjusting, the logistic regression analysis revealed that Q4 group patients (with SIRI ≥2.61) were associated with a higher risk of worsening of LV systolic function (adjusted odds ratio: 1.52, 95% confidence intervals: 1.15-2.01, P =0.003). Approximately 4.0% and 2.0% of the overall association of SIRI with cardiovascular and all-cause mortality were mediated by worsening of left ventricular systolic function (P <0.05), respectively.
Conclusion:
SIRI serve as a potential risk factor for worsening of LV systolic function in CAD patients, and further contributes to poor prognosis, indicating that anti-inflammatory treatment represents a viable approach to improve the prognosis for CAD patients.
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies